Denne forsinkede diagnosticering af overfølsomhed har bevirket, at Ziagen blev fortsat eller re- introduceret og har medført mere alvorlige overfølsomhedsreaktioner eller død.
This delay in diagnosis of hypersensitivity has resulted in Ziagen being continued or re-introduced, leading to more severe hypersensitivity reactions or death.